309 related articles for article (PubMed ID: 34560183)
1. Does immune recognition of SARS-CoV2 epitopes vary between different ethnic groups?
Bose T; Pant N; Pinna NK; Bhar S; Dutta A; Mande SS
Virus Res; 2021 Nov; 305():198579. PubMed ID: 34560183
[TBL] [Abstract][Full Text] [Related]
2. Identification of Novel Candidate CD8
Pushpakumara PD; Madhusanka D; Dhanasekara S; Jeewandara C; Ogg GS; Malavige GN
Viruses; 2021 May; 13(6):. PubMed ID: 34073934
[TBL] [Abstract][Full Text] [Related]
3. A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach.
Oyarzun P; Kashyap M; Fica V; Salas-Burgos A; Gonzalez-Galarza FF; McCabe A; Jones AR; Middleton D; Kobe B
Front Immunol; 2021; 12():598778. PubMed ID: 33717077
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
[TBL] [Abstract][Full Text] [Related]
5. Risk HLA alleles in South America and potential new epitopes for SARS-CoV2.
Sáenz Hinojosa S; Romero V
Hum Immunol; 2021 Aug; 82(8):561-567. PubMed ID: 33972137
[TBL] [Abstract][Full Text] [Related]
6. Immunoinformatics prediction of overlapping CD8
Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
[TBL] [Abstract][Full Text] [Related]
7. Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes.
Poran A; Harjanto D; Malloy M; Arieta CM; Rothenberg DA; Lenkala D; van Buuren MM; Addona TA; Rooney MS; Srinivasan L; Gaynor RB
Genome Med; 2020 Aug; 12(1):70. PubMed ID: 32791978
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.
Schmidt KG; Nganou-Makamdop K; Tenbusch M; El Kenz B; Maier C; Lapuente D; Überla K; Spriewald B; Bergmann S; Harrer EG; Harrer T
Front Immunol; 2021; 12():627568. PubMed ID: 33995351
[TBL] [Abstract][Full Text] [Related]
9. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
Jakhar R; Kaushik S; Gakhar SK
J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
[TBL] [Abstract][Full Text] [Related]
10. CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and prevention.
Guo E; Guo H
PLoS One; 2020; 15(12):e0239566. PubMed ID: 33301503
[TBL] [Abstract][Full Text] [Related]
11. A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population.
Kim GJ; Elnaggar JH; Varnado M; Feehan AK; Tauzier D; Rose R; Lamers SL; Sevalia M; Nicholas N; Gravois E; Fort D; Crabtree JS; Miele L
Front Immunol; 2024; 15():1357731. PubMed ID: 38784379
[TBL] [Abstract][Full Text] [Related]
12. CD8
Qiu C; Xiao C; Wang Z; Zhu G; Mao L; Chen X; Gao L; Deng J; Su J; Su H; Fang EF; Zhang ZJ; Zhang J; Xie C; Yuan J; Luo OJ; Huang LA; Wang P; Chen G
Front Immunol; 2021; 12():764949. PubMed ID: 35116022
[TBL] [Abstract][Full Text] [Related]
13. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
Front Immunol; 2021; 12():692937. PubMed ID: 34497604
[TBL] [Abstract][Full Text] [Related]
14. Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein.
Chukwudozie OS; Gray CM; Fagbayi TA; Chukwuanukwu RC; Oyebanji VO; Bankole TT; Adewole RA; Daniel EM
PLoS One; 2021; 16(3):e0248061. PubMed ID: 33730022
[TBL] [Abstract][Full Text] [Related]
15. Human CD4
Verhagen J; van der Meijden ED; Lang V; Kremer AE; Völkl S; Mackensen A; Aigner M; Kremer AN
Clin Exp Immunol; 2021 Sep; 205(3):363-378. PubMed ID: 34061349
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8
Saini SK; Hersby DS; Tamhane T; Povlsen HR; Amaya Hernandez SP; Nielsen M; Gang AO; Hadrup SR
Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33853928
[TBL] [Abstract][Full Text] [Related]
17. Population-Predicted MHC Class II Epitope Presentation of SARS-CoV-2 Structural Proteins Correlates to the Case Fatality Rates of COVID-19 in Different Countries.
Liang C; Bencurova E; Psota E; Neurgaonkar P; Prelog M; Scheller C; Dandekar T
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807854
[TBL] [Abstract][Full Text] [Related]
18. Development and application of EpitopeScan, a Python3 toolset for mutation tracking in SARS-CoV-2 immunogenic epitopes.
Kovalenko A; Viatte S
Front Immunol; 2024; 15():1356314. PubMed ID: 38840924
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19.
Grifoni A; Sidney J; Vita R; Peters B; Crotty S; Weiskopf D; Sette A
Cell Host Microbe; 2021 Jul; 29(7):1076-1092. PubMed ID: 34237248
[TBL] [Abstract][Full Text] [Related]
20. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
